Filing Flows › Senti Biosciences Holdings (SNTI) › Stock forecast & fair value
Senti Biosciences Holdings (SNTI) stock forecast and price target
Senti Biosciences Holdings (SNTI) trades at $0.16. 2 analysts' median price target is $13.50 (84×), from $12.00 to $15.00.
Senti Biosciences Holdings' latest quarter
Senti Biosciences Holdings, Q2 2026: revenue $17K, net loss $12.8M, operating cash flow −$14.2M. The chart follows the revenue to costs, profit and cash.
Questions
What is the price target for SNTI stock?
The median of 2 analysts' 12-month targets is $13.50, 84× from $0.16; the range is $12.00 to $15.00. The average rating is none.
Does Senti Biosciences Holdings usually beat earnings estimates?
It beat the consensus EPS estimate in 25% of the quarters on record.
Is SNTI stock a buy?
Filing Flows does not give advice. It shows what analysts expect, what each valuation method implies and the figures behind them, read from SEC filings, so you can judge for yourself.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.